| [1] |
GIANNINI EG, PIERI G, LABANCA S, et al. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma[J]. Dig Liver Dis, 2022, 54( 9): 1215- 1221. DOI: 10.1016/j.dld.2022.03.002. |
| [2] |
TRIVEDI PJ, HIRSCHFIELD GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases[J]. Gut, 2021, 70( 10): 1989- 2003. DOI: 10.1136/gutjnl-2020-322362. |
| [3] |
CHEN R, TANG R, MA X, et al. Immunologic responses and the pathophysiology of primary biliary cholangitis[J]. Clin Liver Dis, 2022, 26( 4): 583- 611. DOI: 10.1016/j.cld.2022.06.003. |
| [4] |
XIANG B, DENG C, QIU F, et al. Single cell sequencing analysis identifies genetics-modulated ORMDL3 + cholangiocytes having higher metabolic effects on primary biliary cholangitis[J]. J Nanobiotechnology, 2021, 19( 1): 406. DOI: 10.1186/s12951-021-01154-2. |
| [5] |
YOU H, MA X, EFE C, et al. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis[J]. Hepatol Int, 2022, 16( 1): 1- 23. DOI: 10.1007/s12072-021-10276-63. |
| [6] |
ZHANG X, THOMPKINS-JOHNS A, ZIOBER A, et al. Hepatic macrophage types cluster with disease etiology in chronic liver disease and differ compared to normal liver: implications for their biologic and diagnostic role[J]. Int J Surg Pathol, 2023, 31( 3): 268- 279. DOI: 10.1177/10668969221099630. |
| [7] |
WEN Y, LAMBRECHT J, JU C, et al. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities[J]. Cell Mol Immunol, 2021, 18( 1): 45- 56. DOI: 10.1038/s41423-020-00558-8. |
| [8] |
WANG C, MA C, GONG L, et al. Macrophage polarization and its role in liver disease[J]. Front Immunol, 2021, 12: 803037. doi: 10.3389/fimmu.2021.803037. |
| [9] |
PENG A, KE P, ZHAO R, et al. Elevated circulating CD14 lowCD16 + monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization[J]. Clin Exp Med, 2016, 16( 4): 511- 521. DOI: 10.1007/s10238-015-0381-2. |
| [10] |
ZHAO J, ZHAO S, ZHOU G, et al. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis[J]. Scand J Gastroenterol, 2011, 46( 4): 485- 494. DOI: 10.3109/00365521.2010.539624. |
| [11] |
REUVENI D, BREZIS MR, BRAZOWSKI E, et al. Interleukin 23 produced by hepatic monocyte-derived macrophages is essential for the development of murine primary biliary cholangitis[J]. Front Immunol, 2021, 12: 718841. DOI: 10.3389/fimmu.2021.718841. |
| [12] |
XU J, GUO J, PU XW, et al. Effect of lncRNA-MIAT on M2-type polarization of tumor-associated macrophages and its mechanism[J]. J Jilin Univ(Med Edit), 2022, 48( 6): 1462- 1473. DOI: 10.13481/j.1671-587X.20220612. |
| [13] |
LIANG Y, QIN BD, SHI H, et al. Polarization analysis of peripheral blood mononuclear cells in patients with primary biliary cholangitis[J]. Chin J Clin Lab Sci, 2018, 36( 10): 725- 728. DOI: 10.13602/j.cnki.jcls.2018.10.02. |
| [14] |
XU JM. Tim-3/Galectin-9 pathway regulates macrophage involvement in primary biliary cholangitis[D]. Kunming: Kunming Medical University, 2023.
徐加敏. Tim-3/Galectin-9通路调控巨噬细胞参与原发性胆汁性胆管炎的研究[D]. 昆明: 昆明医科大学, 2023.
|
| [15] |
FU HY, XU JM, AI X, et al. The clostridium metabolite P-cresol sulfate relieves inflammation of primary biliary cholangitis by regulating kupffer cells[J]. Cells, 2022, 11( 23): 3782. DOI: 10.3390/cells11233782. |
| [16] |
RONCA V, MANCUSO C, MILANI C, et al. Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis[J]. J Leukoc Biol, 2020, 108( 2): 659- 671. DOI: 10.1002/JLB.5MR0320-200R. |
| [17] |
WANG Q, WANG Y, QIAO W, et al. The effect of serum IL-2 levels on the prognosis of primary biliary cholangitis-related liver failure and the preliminary exploration of its mechanism[J]. Front Immunol, 2022, 13: 995223. DOI: 10.3389/fimmu.2022.995223. |
| [18] |
BOSSEN L, REBORA P, BERNUZZI F, et al. Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis[J]. Liver Int, 2020, 40( 6): 1408- 1414. DOI: 10.1111/liv.14466. |
| [19] |
FUJINAGA Y, NAMISAKI T, TSUJI Y, et al. Macrophage activation markers predict liver-related complications in primary biliary cholangitis[J]. Int J Mol Sci, 2022, 23( 17): 9814. DOI: 10.3390/ijms23179814. |
| [20] |
GAO LL, ZHANG YJ, GAO XS, et al. Analysis of differential expression of lncRNA and mRNA in liver tissue of female primary biliary cholangitis patients with poor response to ursodeoxycholic acid[J/CD]. Chin J Liver Dis(Electronic Version), 2023, 15( 2): 47- 53. DOI: 10.3969/j.issn.1674-7380.2023.02.008. |
| [21] |
JOHN BV, KHAKOO NS, SCHWARTZ KB, et al. Ursodeoxycholic acid response is associated with reduced mortality in primary biliary cholangitis with compensated cirrhosis[J]. Am J Gastroenterol, 2021, 116( 9): 1913- 1923. DOI: 10.14309/ajg.0000000000001280. |
| [22] |
ALMISHRI W, SWAIN LA, D’MELLO C, et al. ADAM metalloproteinase domain 17 regulates cholestasis-associated liver injury and sickness behavior development in mice[J]. Front Immunol, 2021, 12: 779119. DOI: 10.3389/fimmu.2021.779119. |
| [23] |
BOSSEN L, LAU TS, NIELSEN MB, et al. The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis[J]. Hepatol Commun, 2023, 7( 4). DOI: 10.1097/HC9.0000000000000068. |
| [24] |
YANG P, LIU L, SUN L, et al. Immunological feature and transcriptional signaling of Ly6C monocyte subsets from transcriptome analysis in control and hyperhomocysteinemic mice[J]. Front Immunol, 2021, 12: 632333. DOI: 10.3389/fimmu.2021.632333. |
| [25] |
LEVY C, MANNS M, HIRSCHFIELD G. New treatment paradigms in primary biliary cholangitis[J]. Clin Gastroenterol Hepatol, 2023, 21( 8): 2076- 2087. DOI: 10.1016/j.cgh.2023.02.005. |
| [26] |
OTSUKA M, EGAWA G, KABASHIMA K. Uncovering the mysteries of langerhans cells, inflammatory dendritic epidermal cells, and monocyte-derived langerhans cell-like cells in the epidermis[J]. Front Immunol, 2018, 9: 1768. DOI: 10.3389/fimmu.2018.01768. |
| [27] |
HARADA K, SHIMODA S, IKEDA H, et al. Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3α in the pathogenesis of primary biliary cirrhosis[J]. Liver Int, 2011, 31( 2): 245- 253. DOI: 10.1111/j.1478-3231.2010.02367.x. |
| [28] |
GUILLOT A, WINKLER M, SILVA AFONSO M, et al. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression[J]. Hepatology, 2023, 78( 1): 150- 166. DOI: 10.1097/HEP.0000000000000270. |
| [29] |
KOUROUMALIS E, TSOMIDIS I, VOUMVOURAKI A. Interplay of autophagy, apoptosis, and senescence in primary biliary cholangitis[J]. Explor Dig Dis, 2023, 2: 223- 245. DOI: 10.37349/edd.2023.00028.. |
| [30] |
FU HY, BAO WM, YANG CX, et al. Kupffer cells regulate natural killer cells via the nk group 2, member D(NKG2D)/retinoic acid early inducible-1(RAE-1) interaction and cytokines in a primary biliary cholangitis mouse model[J]. Med Sci Monit, 2020, 26: e923726. DOI: 10.12659/MSM.923726. |
| [31] |
SASAKI M, KAKUDA Y, MIYAKOSHI M, et al. Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis[J]. J Clin Pathol, 2014, 67( 6): 470- 476. DOI: 10.1136/jclinpath-2013-201917. |
| [32] |
WITHEREL CE, SAO K, BRISSON BK, et al. Regulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages[J]. Biomaterials, 2021, 269: 120667. DOI: 10.1016/j.biomaterials.2021.120667. |
| [33] |
ZUO T, XIE Q, LIU J, et al. Macrophage-derived cathepsin S remodels the extracellular matrix to promote liver fibrogenesis[J]. Gastroenterology, 2023, 165( 3): 746- 761. e 16. DOI: 10.1053/j.gastro.2023.05.039. |
DownLoad: